Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasion

Catherine Albright, Debra Van Egeren, Aditya Thakur, Arijit Chakravarty, Laura F. White, Madison Stoddard
doi: https://doi.org/10.1101/2023.01.25.23285031

Article Information

doi 
https://doi.org/10.1101/2023.01.25.23285031
History 
  • January 26, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Catherine Albright1,
  2. Debra Van Egeren2,
  3. Aditya Thakur1,
  4. Arijit Chakravarty3,
  5. Laura F. White4 and
  6. Madison Stoddard3,*
  1. 1Boston University, Boston, MA
  2. 2Stanford University School of Medicine, Stanford, CA
  3. 3Fractal Therapeutics, Cambridge, MA
  4. 4Boston University School of Public Health, Boston, MA
  1. ↵*Corresponding author; email: madison.stoddard{at}fractaltx.com
Back to top
Posted January 26, 2023.
Download PDF
Data/Code
Email
Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasion
Catherine Albright, Debra Van Egeren, Aditya Thakur, Arijit Chakravarty, Laura F. White, Madison Stoddard
medRxiv 2023.01.25.23285031; doi: https://doi.org/10.1101/2023.01.25.23285031
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area